We are live on ! Find out more
CF

Cantor Fitzgerald Portfolio holdings

AUM $6.78B
1-Year Est. Return 29.01%
This Fund
S&P 500
This Quarter Est. Return
+22.45%
1 Year Est. Return
+29.01%
3 Year Est. Return
+173.81%
5 Year Est. Return
10 Year Est. Return
AUM
$424M
AUM Growth
-$63.1M
Cap. Flow
+$663M
Cap. Flow %
156.34%
Top 10 Hldgs %
58.91%
Holding
374
New
118
Increased
27
Reduced
42
Closed
99

Sector Composition

Rank Sector Weight
1 Financials 18.9%
2 Communication Services 18.51%
3 Technology 14.28%
4 Materials 6.91%
5 Healthcare 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOXO
226
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
$11.1K ﹤0.01%
9,572
CDLX icon
227
CALL
Cardlytics
CDLX
$22.1M
$10.8K ﹤0.01%
+1,000
New +$84.4K
ZCARW
228
DELISTED
Zoomcar Holdings, Inc. Warrants
ZCARW
$10.1K ﹤0.01%
324,999
VCXB.WS
229
DELISTED
10X Capital Venture Acquisition Corp III Warrants
VCXB.WS
$10K ﹤0.01%
250,000
CCGWW
230
Cheche Group Inc Warrant
CCGWW
$9.86K ﹤0.01%
101,608
HYMCW
231
DELISTED
Hycroft Mining Holding Corporation Warrant
HYMCW
$9.77K ﹤0.01%
670,600
BCSAW
232
DELISTED
Blockchain Coinvestors Acquisition Corp. I Warrant
BCSAW
$9.24K ﹤0.01%
249,700
ALCYW
233
DELISTED
Alchemy Investments Acquisition Corp 1 Warrants
ALCYW
$8.48K ﹤0.01%
39,300
COCHW icon
234
Envoy Medical Warrant
COCHW
$510K
$8.43K ﹤0.01%
93,480
NKLA
235
PUT
DELISTED
Nikola Corporation Common Stock
NKLA
$8.43K ﹤0.01%
+1,813
New +$38.9K
ANVS icon
236
PUT
Annovis Bio
ANVS
$75.3M
$7.8K ﹤0.01%
+26,000
New +$284K
ROIV icon
237
CALL
Roivant Sciences
ROIV
$24.8B
$7.78K ﹤0.01%
+73,000
New +$787K
BAERW icon
238
Bridger Aerospace Warrant
BAERW
$13.4M
$7.22K ﹤0.01%
40,113
CLOER
239
DELISTED
Clover Leaf Capital Corp. Rights
CLOER
$6.14K ﹤0.01%
49,900
LSBPW
240
DELISTED
LakeShore Biopharma Warrants
LSBPW
$6K ﹤0.01%
76,931
HSCS icon
241
Heart Test Laboratories
HSCS
$6.84M
$5.84K ﹤0.01%
500
TLSA icon
242
Tiziana Life Sciences
TLSA
$123M
$5.49K ﹤0.01%
12,091
TH icon
243
CALL
Target Hospitality
TH
$1.44B
$5.37K ﹤0.01%
+8,600
New +$80.8K
XFINW
244
DELISTED
ExcelFin Acquisition Corp Warrant
XFINW
$5K ﹤0.01%
100,000
BLUA.WS
245
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$4.47K ﹤0.01%
49,999
SVIIR
246
DELISTED
Spring Valley Acquisition Corp II Rights
SVIIR
$3.33K ﹤0.01%
29,690
ESHAR
247
DELISTED
ESH Acquisition Corp Right
ESHAR
$3.01K ﹤0.01%
35,804
WKHS icon
248
Workhorse Group
WKHS
$34.5M
$3.01K ﹤0.01%
4
OAKUR
249
DELISTED
Oak Woods Acquisition Corp Right
OAKUR
$2.55K ﹤0.01%
+15,000
New +$2.17K
TRTL.WS
250
DELISTED
TortoiseEcofin Acquisition Corp. III Warrant, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TRTL.WS
$2.53K ﹤0.01%
25,325

Similar funds

Cantor Fitzgerald's Q1 2024 Portfolio in Review

As of Q1 2024, Cantor Fitzgerald held 374 positions worth $424M, down 13% from $487M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Cantor Fitzgerald deployed $663M of net new capital in Q1 2024, opening 118 new positions and adding to 27 existing holdings. Its largest new stake was Critical Metals Corp: 1,247,250 shares worth $16.7M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 21% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Battery Future Acquisition Corp., an estimated $26.9M trimmed.

  • Cantor Fitzgerald's largest Q1 2024 buy was Critical Metals Corp: 1,247,250 shares worth $16.7M.
  • Cantor Fitzgerald added most to Advanced Micro Devices in Q1 2024, an estimated $8.53M increase.
  • Cantor Fitzgerald's biggest Q1 2024 reduction was Battery Future Acquisition Corp., cutting an estimated $26.9M.
  • Cantor Fitzgerald fully exited GSK in Q1 2024, selling an estimated $23.7M.
  • Cantor Fitzgerald's ten largest holdings make up 59% of its $424M portfolio in Q1 2024.
  • Cantor Fitzgerald opened 118 new positions and closed 99 in Q1 2024.
  • Cantor Fitzgerald's portfolio value fell 13% quarter-over-quarter to $424M.

Based on Cantor Fitzgerald's 13F filing for Q1 2024, filed 15 May 2024.